Auto tariffs can't realistically stick, even as Trump calls them permanent, say analysts
Industry dealers and analysts are reacting to the news of Trump's 25% tariffs on imported vehicles saying it will ...
U.S. Faces ‘Significant Risks’ From Debt, Analysts Say, as Trump Pursues Tax Agenda
At its current rate of borrowing, the country’s debt as a share of the economy will reach 118% in 2035, the Congressional ...
US corporate profits surge in Q4 amid tariff uncertainty
U.S. corporate profits rebounded sharply in the fourth quarter, but incoming tariffs are creating a challenging environment ...
Marketplace4h
What can the latest GDP numbers tell us about where the economy is headed?
GDP figures showed a gradual economic slowdown. Thanks to uncertainty, some economists say the slowdown might be quicker.
Analyst Estimates: Here's What Brokers Think Of Ströer SE & Co. KGaA (ETR:SAX) After Its Yearly Report
Ströer SE & Co. KGaA ( ETR:SAX ) came out with its yearly results last week, and we wanted to see how the business ...
U.S. cities located in states won by Trump would be most hurt by Canadian tariffs, an analysis finds
The analysis released Thursday finds San Antonio and Detroit top the list of 41 metro areas most dependent on exports to Canada.
Is Micron Technology Stock Going to $163? 1 Wall Street Analyst Thinks So.
The stock is trading at 13 times this year's earnings estimate, which is below its historical average price-to-earnings ratio ...
Trump’s 25% car tariff rattles markets: EU industry leaders, analysts react
Trump’s 25% tariff on auto imports jolts equity markets and draws backlash, with European industry groups warning of supply ...
Opinion
Zacks Investment Research on MSN5hOpinion
Top Analyst Reports for Walt Disney, Progressive & Citigroup
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Co. (DIS), The ...
Soleno jumps as analysts say US nod for rare disease drug transforms treatment options
Shares of Soleno Therapeutics jumped 40% in morning trading on Thursday, after the company's drug for a rare metabolic condition became the first such treatment to receive U.S. regulatory nod.
Southern states' share in India's GDP has caught up with that of North, Central India: MC Analysis
In 1970-71, the share of northern states in the Indian economy was 40 percent higher than that of South India, which had a 24 ...
How Major Car Brands Are Affected by Trump’s Tariffs
The company run by Mr. Trump’s confidant, Elon Musk, makes the cars it sells in the United States in factories in California ...